Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014:2014:834537.
doi: 10.1155/2014/834537. Epub 2014 Oct 16.

Modified kraske procedure with mid-sacrectomy and coccygectomy for en bloc excision of sacral giant cell tumors

Affiliations

Modified kraske procedure with mid-sacrectomy and coccygectomy for en bloc excision of sacral giant cell tumors

Vítor M Gonçalves et al. Case Rep Surg. 2014.

Abstract

Sacral giant cell tumors are rare neoplasms, histologically benign but potentially very aggressive due to the difficulty in achieving a complete resection, their high recurrence rate, and metastization capability. Although many treatment options have been proposed, en bloc excision with tumor-free margins seems to be the most effective, being associated with long term tumor control, improved outcome, and potential cure. An exemplifying case of a 29-year-old female with progressive complaints of pain and paresthesias in the sacral and perianal regions, constipation, and weight loss for 6 months is presented. The surgical technique for en bloc excision of a large sacral giant cell tumor through a modified Kraske procedure with mid-sacrectomy and coccygectomy is described. Complete resection with wide tumor-free margins was achieved. At 5 years of follow-up the patient is neurologically intact, without evidence of local recurrence on imaging studies. A multidisciplinary surgical procedure is mandatory to completely remove sacral tumors. In the particular case of giant cell tumors, it allows minimizing local recurrence preserving neurovascular function, through a single dorsal and definitive approach.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Preoperative T2-weighted contrast enhanced MRI showing an expansive and osteolytic lower and mid-sacral lesion, extending up to the inferior half of S2 vertebra, with both intra- and extracanalar components and a ventral extension displacing the rectum anteriorly. (a) Coronal, (b) sagittal, and (c) axial views.
Figure 2
Figure 2
Previewed en bloc excision of the tumor on coronal MRI. Green and yellow lines represent the limits of the specimen to be resected, respectively, corresponding to the 3 sacral osteotomies and the inferior margin around the tumor.
Figure 3
Figure 3
Exposition of dorsal fascia from lumbosacral junction to the tip of the coccyx.
Figure 4
Figure 4
Inferior soft tissue dissection exposing the tip of the coccyx.
Figure 5
Figure 5
Initial finger dissection used to mobilize the rectum.
Figure 6
Figure 6
Kraske procedure providing access between mesorectum and presacral component of the tumor.
Figure 7
Figure 7
Superior subperiosteal dissection.
Figure 8
Figure 8
Soft tissues intentionally left behind and included in the specimen to be resected.
Figure 9
Figure 9
Thecal sac ligation distal to S2 nerve roots (red line).
Figure 10
Figure 10
Representation in a model of the 3 osteotomies performed (green lines) and the level of thecal sac ligation (thin red line). (a) Posterior view and (b) anterior view.
Figure 11
Figure 11
En bloc resected specimen. (a) Ventral surface and (b) dorsal surface.
Figure 12
Figure 12
S2 nerve roots were preserved and remained intact along their entire length.
Figure 13
Figure 13
Rotational flaps of the gluteus maximus provided for soft tissue reconstruction and wound closure.
Figure 14
Figure 14
(a) Hematoxylin-eosin stained tissue demonstrated a highly cellular, solid neoplasm consisting of mononuclear cells and osteoclast-like giant cells; (b) intense immunohistochemical staining for CD68 (KP1).
Figure 15
Figure 15
MRI scan evaluation 5 years after surgery, showing no recurrence of the tumor. (a) Coronal and (b) sagittal views.

References

    1. Mendenhall W. M., Zlotecki R. A., Scarborough M. T., Gibbs C. P., Mendenhall N. P. Giant cell tumor of bone. American Journal of Clinical Oncology: Cancer Clinical Trials. 2006;29(1):96–99. doi: 10.1097/01.coc.0000195089.11620.b7. - DOI - PubMed
    1. Randall R. L. Giant cell tumor of the sacrum. Neurosurgical Focus. 2003;15(2, article E13) - PubMed
    1. Sung H. W., Shu W. P., Wang H. M., Yuai S. Y., Tsai Y. B. Surgical treatment of primary tumors of the sacrum. Clinical Orthopaedics and Related Research. 1987;215:91–98. - PubMed
    1. Turcotte R. E., Sim F. H., Unni K. K. Giant cell tumor of the sacrum. Clinical Orthopaedics and Related Research. 1993;(291):215–221. - PubMed
    1. Campanacci M., Baldini N., Boriani S., Sudanese A. Giant-cell tumor of bone. Journal of Bone and Joint Surgery—Series A. 1987;69(1):106–114. - PubMed

LinkOut - more resources